Dergiler / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 3

Rational Defensive Medicine: Putting an End to the Nationwide Favipiravir Debate

Sayfa
372–373
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

ÖNCEL, S. (2022). Rational Defensive Medicine: Putting an End to the Nationwide Favipiravir Debate. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 3, 372–373. https://ajindex.com/articles/417329

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Karabayır N, Öçal Doğan Ö, Canbeyli G. Use of favipiravir in lactating mother with COVID-19. Turk Arch Pediatr. 2021
  2. 56(5):533- 534. [CrossRef] 2. Appili Therapeutics provides update on Phase 3 PRESECO clinical trial evaluating Avigan®/ReeqonusTM. Available at: https://ww w.businesswire.com/news/home/20211112005554/en/Appili-T herapeutics-Provides-Update-on-Phase-3-PRESECO-Clinical -Trial-Evaluating-Avigan%C2%AEReeqonus%E2%84%A2
  3. Accessed January 12, 2022. 3. Chuah CH, Chow TS, Hor CP, et al. Efficacy of early treatment with favipiravir on disease progression among high risk COVID-19 patients: a randomized, open-label clinical trial. Clin Infect Dis. 2021:ciab962. [CrossRef] 4. Erişkin Hasta Tedavisi. Available at: https://covid19.saglik.gov.tr/ TR-66926/eriskin-hasta-tedavisi.html. Accessed January 12, 2022. 5. Çocuk Hasta Yönetimi ve Tedavi. Available at: https://covid19.sagl ik.gov.tr/TR-66342/cocuk-hasta-yonetimi-ve-tedavi.html. Accessed January 12, 2022. 6. KLİMİK Derneği’nden Erişkinlerde COVID-19’un Anti-Viral Tedavisi İçin Öneriler-2 | KLİMİK. Available at: https://www.klimik.org.tr /2021/12/13/eri skinlerde-covid-19un-anti -viral-tedavisi/. Accessed January 13, 2022. 7. Sonuç Bildirgesi | KLİMİK. Available at: https://www.klimik.org.tr/ simpozyum-ve-konferanslar/klimik-covid-19-simpozyumu-10-12- eylul-2021-istanbul/klimik-covid-19-simpozyumu-sonuc-bildirg esi/. Accessed January 13, 2022. 8. Manabe T, Kambayashi D, Akatsu H, Kudo K. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021
  4. 21(1):489. [CrossRef] 9. Hassanipour S, Arab-Zozani M, Amani B, Heidarzad F, Fathalipour M, Martinez-de-Hoyo R. The efficacy and safety of favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Sci Rep. 2021:11(1):11022. [CrossRef] 10. Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial — PRINCIPLE Trial. Available at: https://www.principletrial.org/news/favipiravir-to -be-investigated-as-a-possible-covid-19-treatment-for-at-hom e-recovery-in-the-principle-trial. Accessed January 12, 2022.